Illumine Investment Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Illumine Investment Management, LLC
- $122 Billion
- Q1 2025
A detailed history of Illumine Investment Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Illumine Investment Management, LLC holds 26,530 shares of AMPH stock, worth $666,433. This represents 0.63% of its overall portfolio holdings.
Number of Shares
26,530
Previous 17,049
55.61%
Holding current value
$666,433
Previous $633 Million
21.5%
% of portfolio
0.63%
Previous 0.52%
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
262Shares Held
34.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$149 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$68.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.1 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$34.5 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...